Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-25-006033

EVP R&D, Chief Medical Officer gave up 3,950 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 8,896 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-18 Option exercise +8,896 66,771 D: show line 1 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-18 Shares withheld for taxes −3,950 $35.90 $141,805 62,821 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-18 Option exercise · Restricted Stock Unit Award −8,896 8,897 D: show line 3 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-19 Grant or award · Employee Stock Option (Right to Buy) +63,991 63,991 D: show line 4 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-19 Grant or award · Restricted Stock Unit Award +30,692 30,692 D: show line 5 in the form
Loading xslF345X05/form4.xml…